Pharmacokinetics and clinical effects of pirfenidone administered intravenously in horses.

The research paper discusses a study that examined the effects and actions of the drug pirfenidone when introduced intravenously to the body of healthy horses.

Study Design and Methodology

• The authors utilized 6 adult horses for this research. Each horse was given a dose of pirfenidone, with the quantity calculated at 15 mg/kg. The drug was introduced into the horse’s body intravenously over a time span of 5 minutes.
• The study was designed to record various physical variables and collect blood samples at multiple points throughout the process. Data was collected before the infusion started; 2.5 minutes after the start of the infusion; at the end of the infusion; and at various points ranging from 3 minutes to 24 hours after the end of the infusion.
• The goal of this structured data collection was to monitor and analyze the plasma concentrations of pirfenidone and any metabolites it produced in the horses’ body.

Study Results

• During the administration phase of the drug, some mild clinical effects, such as increased heart rate (tachycardia) and muscle twitching (fasciculations), were observed. These effects ceased once the drug administration was complete.
• By the end of the 5-minute infusion, the presence of pirfenidone and 2 of its metabolites, carboxypirfenidone and hydroxypirfenidone, were confirmed in the horses’ bloodstream.
• The peak plasma concentration of pirfenidone was measured at 182.5 micromol/L. This peak concentration was observed right at the end of the infusion process. The metabolites reached their peak plasma concentrations somewhat later, 40 minutes after the completion of the infusion, with hydroxypirfenidone recorded at 1.07 micromol/L and carboxypirfenidone at 3.4 micromol/L.
• After 24 hours, the researchers could no longer detect any trace of either the drug or its metabolites in the horses’ circulation.

Data Analysis and Conclusion

• The study found that the distribution of pirfenidone in the horses’ bodies followed a two-compartment model. The drug had a mean elimination half-life of 86.0 minutes, indicating a reasonably rapid clearing of the drug from the body. This finding was supported by a mean body clearance rate recorded at 6.54 mL/kg/min.
• The apparent volume of distribution at steady state was 0.791 L/kg, providing further insight about how the drug dispersed itself once in the body and how it interacted with other elements in the body.
• The conclusion of the study was that the administration of pirfenidone intravenously is generally well-tolerated by healthy horses, with transient adverse effects experienced during the infusion process. However, the clearance of the drug from the body is quite rapid.